BioSpace News Archive

Ophthotech Corporation (NASDAQ: OPHT) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will present an overview of the Company at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will provide an update on its research and development programs in respiratory syncytial virus (RSV), hepatitis B virus

Horizon Pharma plc (Nasdaq: HZNP) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a collaboration to discover and develop novel therapeutics for gout.

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the promotion of Holly Whittemore, C.P.A., to Chief Financial Officer and Abbas Kazimi to Vice President of Business Development

Tarveda Therapeutics, a clinical stage biopharmaceutical company discovering and developing a new class of potent and selective miniature drug conjugates (Pentarins®) for the treatment of patients with a wide range of solid tumors today announced that Drew Fromkin, President and Chief Executive Officer, will present at the 11th Annual Biotech Showcase, occurring January 7-9, 2019 at the Hilton Union Square in San Francisco.

Verastem, Inc. today announced that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 11:00 a.m. PST in San Francisco, CA.

Allergan plc today announced it intends to release fourth quarter and full year 2018 financial results on Tuesday, January 29, 2019, prior to the open of U.S. Financial Markets.

R&D Executive with Proven Track Record in the Biopharmaceutical Industry

Forge Therapeutics, Inc. announced today that it has received a second CARB-X award for developing a novel antibacterial therapeutic agent.

The Los Angeles Chargers Girls will also be visiting to help bring awareness to this community-driven initiative